| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.2 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |